IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 31 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $810,000 | -3.1% | 760,000 | 0.0% | 0.00% | – |
Q1 2019 | $836,000 | +4.0% | 760,000 | -11.6% | 0.00% | – |
Q4 2018 | $804,000 | -9.6% | 860,000 | +25.5% | 0.00% | – |
Q3 2018 | $889,000 | +24.2% | 685,000 | +26.9% | 0.00% | – |
Q2 2018 | $716,000 | -27.6% | 540,000 | -35.7% | 0.00% | – |
Q1 2018 | $989,000 | +0.7% | 840,000 | -0.9% | 0.00% | – |
Q4 2017 | $982,000 | -2.6% | 848,000 | 0.0% | 0.00% | – |
Q3 2017 | $1,008,000 | +37.5% | 848,000 | +54.7% | 0.00% | – |
Q2 2017 | $733,000 | +51.1% | 548,000 | +40.5% | 0.00% | – |
Q1 2017 | $485,000 | – | 390,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 11,901 | $11,946,000 | 2.07% |
Context Capital Management, LLC | 1,000,000 | $997,000 | 0.56% |
WOLVERINE ASSET MANAGEMENT LLC | 33,392,000 | $33,442,000 | 0.42% |
SSI INVESTMENT MANAGEMENT LLC | 3,000,000 | $2,991,000 | 0.22% |
CSS LLC/IL | 2,876,000 | $2,883,000 | 0.18% |
PALISADE CAPITAL MANAGEMENT, LP | 5,000,000 | $5,016,000 | 0.15% |
HBK INVESTMENTS L P | 10,116,000 | $10,186,000 | 0.13% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 1,817,000 | $1,835,000 | 0.11% |
LINDEN ADVISORS LP | 6,269,000 | $6,290,000 | 0.08% |
LAZARD ASSET MANAGEMENT LLC | 15,000,000 | $15,028,000 | 0.02% |